Samuel S. Dychter

Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

Éric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 405 citations · Full text

Medicine, Gynecology, Oncology +13

Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

Jayesh Desai, Leila Yassa, Ellen Marqusee et al. · Annals of Internal Medicine · 2006 · 404 citations

Medicine, Endocrinology, Pharmacotherapy +17

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

Sunil R. Hingorani, William Proctor Harris, J. Thaddeus Beck et al. · Clinical Cancer Research · 2016 · 323 citations · Full text

Medicine, Oncology, Pharmacology +13

Encorafenib, Cetuximab, and mFOLFOX6 in <i>BRAF</i> -Mutated Colorectal Cancer

Elena Élez, Takayuki Yoshino, Lin Shen et al. · New England Journal of Medicine · 2025 · 108 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

High Incidence and Clinical Course of Aggressive Skin Cancer in Heart Transplant Patients: A Single-Center Study

Robert Adamson, E Obispo, Samuel S. Dychter et al. · Transplantation Proceedings · 1998 · 83 citations

Medicine, Dermatology, Oncology +17